IL6 and neoplasm: The protective effects of the KD appear to be mediated through metabolic reprogramming that reduces substrate availability for lipogenesis and inflammatory pathways, enhanced apoptotic regulation via caspase-3 activation and p21-mediated cell cycle arrest, and modulation of the tumor microenvironment characterized by lower IL-6 and cholesterol-driven pro-tumor signaling.